Onyx Pharmaceuticals

Onyx Pharmaceuticals is a biotechnology company focused on developing innovative therapies for cancer. Founded in 1992, it specializes in creating targeted treatments that aim to improve the effectiveness of cancer care while minimizing side effects. One of its well-known products is Kyprolis, used to treat multiple myeloma, a type of blood cancer. Onyx emphasizes research and collaboration to bring new medications from the lab to patients. The company was acquired by Amgen in 2013, expanding its capabilities within the broader landscape of cancer treatment.